Cell-free protein synthesis of influenza virus hemagglutinin HA2-integrated virosomes for siRNA delivery.
Cell-free protein synthesis
Influenza virus hemagglutinin HA2
Lipid nanoparticles
Virosome
pH dependent
siRNA delivery
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Jul 2022
25 Jul 2022
Historique:
received:
21
02
2022
revised:
13
05
2022
accepted:
01
06
2022
pubmed:
12
6
2022
medline:
14
7
2022
entrez:
11
6
2022
Statut:
ppublish
Résumé
It is well known that the difficulty of siRNA therapeutic application is the lack of safe and effective delivery vector. Virosome is a nano vesicle composed of lipid membrane and membrane protein. It retains fusion protein without virus genetic material, and therefore has the reduced immunogenicity compared with viral vector. Virosomes have the potential to deliver protein and nucleic acid drugs, but the traditional preparation method of virosomes is quite limited. In this study, we firstly proposed to synthesize influenza virus hemagglutinin HA2 virosomes by cell-free protein synthesis. In this study, liposomes provided the hydrophobic lipid bilayer environment for the formation of HA2 protein multimer, which inhibited the aggregation of hydrophobic HA2 and improved HA2 protein expression. Chitosan as a rigid core adsorbed siRNA and improved the encapsulation efficiency of siRNA. In conclusion, the cell-free protein synthesis was used to prepare HA2 virosomes, which paves the way for constructing a novel nano vector with high delivery efficiency and biosafety for the delivery of siRNA.
Identifiants
pubmed: 35690307
pii: S0378-5173(22)00445-8
doi: 10.1016/j.ijpharm.2022.121890
pii:
doi:
Substances chimiques
Hemagglutinin Glycoproteins, Influenza Virus
0
Hemagglutinins
0
Liposomes
0
RNA, Small Interfering
0
Virosomes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121890Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.